Articles Tagged With:
-
Early Initiation of Postmenopausal Estrogen Therapy
Women randomized to oral estradiol therapy showed less progression of subclinical atherosclerosis than those who received placebo.
-
Clinical Briefs
In this section: watching carefully for suicide risk; tackling chronic cough; and a new treatment for Peyronie's disease.
-
Reslizumab Injection (Cinqair)
Reslizumab is indicated for add-on maintenance treatment of adult patients with severe asthma with eosinophilic phenotype.
-
Longer Course Therapy for Lyme Disease Is Not Beneficial
A randomized, placebo-controlled clinical trial from the Netherlands found that longer-term antibiotic therapy for Lyme disease did not improve health-related quality of life compared to a standard course of treatment.
-
Predicting Seizure Recurrence with Routine EEG After First Unprovoked Seizure
Using positive likelihood ratios, an adult and child with epileptiform discharges on electroencephalography were estimated to have a 77% and 66% probability, respectively, of recurrent seizures.
-
Too Much of a Good Thing
In the United States in 2010 and 2011, an estimated 30% of outpatient oral antibiotic prescriptions may have been inappropriate, a finding that supports the need for establishing a goal for outpatient antibiotic stewardship.
-
'Substantial' Settlement Reached in Joan Rivers’ Death
The physicians who were sued by the family have accepted responsibility for her death. -
Does Phone Consult Establish Patient-Physician Relationship?
EPs cannot safely assume that a consultant who gives advice over the phone will be held liable if a bad outcome results.
-
Settlement of Med/Mal Claim Could Cause EP Unexpected Problems
A quick settlement can seem very appealing to any EP defendant facing protracted litigation, but EPs should be aware of the repercussions.
-
EP Failed to Administer tPA for Stroke: Is Malpractice Claim Defensible?
Reasoning must be clear in ED chart.